UP lady cop who stood up against BJP leaders, shunted out

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

New Delhi, Jun 30: With a spike of 18,522 COVID-19 cases in the last 24 hours, India's coronavirus count now stand at 5,66,840, said the Union Health and Family Welfare Ministry on Tuesday.

According to the Ministry, 418 deaths due to COVID-19 were reported in the last 24 hours. The number of deaths in the country now stands at 16,893.

There are 2,15,125 active coronavirus cases in the country while the number of cured/discharged patients stands at 3,34,821 and one patient migrated.

As per the Ministry, Maharashtra is the worst-hit state with regard to the COVID-19 cases and has reported 1,69,883 cases, including 73, 313 active cases 88,960 cured/discharged patients and 7,610 fatalities.

Tamil Nadu has a total of 86,224 cases including 1,141 deaths. Delhi's COVID-19 count stands at 85,161 cases and 2,680 fatalities.

The total number of samples tested up to 29 June is 86,08,654 of which 2,10,292 samples were tested yesterday, informed the Indian Council of Medical Research.

Apr 13: The Supreme Court of India has said Indian expatriates stranded abroad cannot be flown back immediately. All petitions before India's apex court which sought directions or orders to 'bring back Indians stranded in various countries abroad' has been deferred for four weeks, according to Indian media reports.

The Chief Justice of India Sharad Arvind Bobde led bench took up matters pertaining to evacuation of Indian citizens stranded abroad amid the Covid19 pandemic.
Supreme Court today deferred for 4 weeks, all the petitions before it which sought directions or orders to 'bring back Indians stranded in various countries abroad'.

A total of seven petitions seeking directions from Court on the immediate evacuation of Indian nationals from UK, US, Iran and Gulf countries were taken up simultaneously.

Bobde said, "Stay where you are. People in other countries cannot be brought back right now"

Foreigners stuck in India granted visa extension

Furthermore, the Indian Ministry of Home Affairs (MHA) has announced a visa extension for all foreigners who are stranded in in India due to ongoing travel restrictions imposed by the government.

Regular visa,e-visa or stay stipulation of such foreigners stranded in India due to travel restrictions by Indian Authorities&whose visas have expired/would be expiring between 01.02&30.04, would be extended till 30 April on gratis basis,after online application by foreigners:MHA